Autoimmune Disease News and Research

RSS
Researchers examine how fermented vegetables affect inflammation markers in women

Researchers examine how fermented vegetables affect inflammation markers in women

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

Study may have solved a mystery surrounding Crohn’s disease

Study may have solved a mystery surrounding Crohn’s disease

Study reveals a testable hypothesis to explain the initiation of autoimmunity in T1D patients

Study reveals a testable hypothesis to explain the initiation of autoimmunity in T1D patients

Study shows 72% increase in new diagnoses of type 1 diabetes in young COVID-19 patients

Study shows 72% increase in new diagnoses of type 1 diabetes in young COVID-19 patients

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Extra caution needed while screening depressed teenagers with Type 1 diabetes

Extra caution needed while screening depressed teenagers with Type 1 diabetes

Study provides a potential game-changer in assessing treatment response in pancreatic cancer patients

Study provides a potential game-changer in assessing treatment response in pancreatic cancer patients

Clinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritis

Clinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritis

Tight control of blood sugar in teens may help reduce diabetes-related brain damage

Tight control of blood sugar in teens may help reduce diabetes-related brain damage

People with autoimmune disorder have a higher risk of developing cardiovascular disease

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Scientists begin phase 2 clinical trials of lupus pill

Scientists begin phase 2 clinical trials of lupus pill

Interferon beta reduces binding of three components to RBCs, study finds

Interferon beta reduces binding of three components to RBCs, study finds

Study uncovers new prognostic marker for multiple sclerosis severity

Study uncovers new prognostic marker for multiple sclerosis severity

Eating fish and seafood reduces risk of rheumatoid arthritis

Eating fish and seafood reduces risk of rheumatoid arthritis

ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune response

ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune response

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Unlocking the power of proteins to better understand human health

Unlocking the power of proteins to better understand human health

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

The impact of glucocorticoid therapy on immune responses to COVID-19 vaccination or infection in rituximab-treated patients with autoimmune disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.